# Basil S. Lewis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/basil-s-lewis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 80,944 |
| Field | Cardiac Imaging and Diagnostics |
| h-index | 80 |
| i10-index | 239 |
| Last Known Institution | Technion – Israel Institute of Technology |
| OpenAlex ID | https://openalex.org/A5007389891 |
| ORCID iD | https://orcid.org/0000-0001-5604-6399 |
| Works | 431 |

## Researcher papers

Showing 12 of 18.

- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Apixaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials](https://scholariq.org/papers/comparison-of-the-efficacy-and-safety-of-new-oral-anticoagulants-with-warfarin/)
- [2023 ESC Guidelines for the management of acute coronary syndromes](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-acute-coronary-syndromes/)
- [Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes](https://scholariq.org/papers/ezetimibe-added-to-statin-therapy-after-acute-coronary-syndromes/)
- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-2/)
- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [2020 ESC Guidelines for the management of adult congenital heart disease](https://scholariq.org/papers/2020-esc-guidelines-for-the-management-of-adult-congenital-heart-disease/)
- [2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy](https://scholariq.org/papers/2021-esc-guidelines-on-cardiac-pacing-and-cardiac-resynchronization-therapy/)
- [Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-peripheral-or/)
- [Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial](https://scholariq.org/papers/ferric-carboxymaltose-for-iron-deficiency-at-discharge-after-acute-heart-failure/)
- [Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial](https://scholariq.org/papers/heart-failure-saxagliptin-and-diabetes-mellitus-observations-from-the-savor-timi/)

## Researcher topics

- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

## Researcher university

- [Technion – Israel Institute of Technology](https://scholariq.org/institutions/technion-israel-institute-of-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.